=LDR  00000nam  2200000   4500
=001  INLIS000000000003250
=005  20221026100548
=035  ##$$a 0010-0520003250
=008  221026################|##########|#eng##
=020  ##$$a 0-471-22878-8
=041    $$a eng
=082  ##$$a 338.70973
=084  ##$$a 338.70973 HOW m
=100   #$$a Howthorne, Fran
=245  14$$a Merck Druggernaunt : $b the Inside Story of a Pharmaceutical Giant /$c Fran Howthorne
=260  ##$$a New Jersey :$b John Wiley & Sons,$c 2003
=300  ##$$a xiv, 290 p. ; $c 22 cm.
=500  ##$$a Indeks : p. 282-290
=504  ##$$a p. 279-282
=520  ##$$a An in--depth look at big pharma's flagship company This book takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author the one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names.
=650   4$$a Merck & Co
=650   4$$a Pharmaceutical Industry-United States
=990  ##$$a 11227/MKRI-P/XII-2008 
=990  ##$$a 11228/MKRI-P/XII-2008 
=990  ##$$a 11227/MKRI-P/XII-2008 
=990  ##$$a 11228/MKRI-P/XII-2008 
=990  ##$$a 11228/MKRI-P/XII-2008 
=990  ##$$a 11227/MKRI-P/XII-2008